We employ advanced quantitative imaging techniques to better understand neurological disease in a variety of settings and pathologies, including meningiomas, glioblastoma, CNS lymphoma, diffuse midline glioma, Alzheimer's disease, adrenoleukodystrophy, and a variety of others conditions.
